» Articles » PMID: 39407138

Estimation of the Prevalence of Anxiety During the COVID-19 Pandemic: A Meta-analysis of Meta-analyses

Overview
Publisher Biomed Central
Specialty Public Health
Date 2024 Oct 15
PMID 39407138
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pandemics such as COVID-19, can lead to psychiatric symptoms like anxiety. It seems that meta-analysis of meta-analysis studies can provide more comprehensive information regarding the needs for post-COVID-19 services. Therefore, this umbrella review and meta-analysis of meta-analyses aimed to estimate the precise prevalence of anxiety during the COVID-19 pandemic.

Methods: PubMed, Scopus, and Web of Science were searched for published meta-analyses using relevant keywords, such as Anxiety, Prevalence, COVID-19, and Meta-analysis up to November 1, 2023. Google Scholar, reference check, citation check, and grey literature were manually searched. A random-effect model was used for the analysis. All analyses were conducted using STATA: 17.

Results: Out of the 4263 records, Finally, 75 meta-analyses were included. The overall prevalence of anxiety was 30.4% [95% CI: 29-31.8] with a high heterogeneity (I: 86.76%). The highest prevalence of anxiety according to population type was 41.3% in patients and then in students (30.8), pregnant women (30.6%), and health care workers (30.5%). The Result of meta-regression showed that "Time" (based on the time between the start of COVID-19 and the last search date in articles) was not a significant predictor of the prevalence of anxiety (R Coefficient = 0.000149, P = 0.61).

Conclusions: Considering the prevalence of anxiety among patients, students, pregnant women, and healthcare workers, special attention should be paid to these groups in case of the re-occurrence of COVID-19 or occurrence of other pandemics. As quarantine due to pandemics causes reduced social interactions, reduced income, and increased worry about severe illness and death, there is a need for large-scale mobilization of political measures.

Citing Articles

An umbrella review of the prevalence of depression during the COVID-19 pandemic: Call to action for post-COVID-19 at the global level.

Mohseni M, Azami-Aghdash S, Bashzar S, Mousavi Isfahani H, Parnian E, Amini-Rarani M BMC Public Health. 2024; 24(1):3562.

PMID: 39716132 PMC: 11664853. DOI: 10.1186/s12889-024-21085-5.

References
1.
Mohseni M, Ahmadi S, Azami-Aghdash S, Mousavi Isfahani H, Moosavi A, Fardid M . Challenges of routine diabetes care during COVID-19 era: A systematic search and narrative review. Prim Care Diabetes. 2021; 15(6):918-922. PMC: 8326007. DOI: 10.1016/j.pcd.2021.07.017. View

2.
Gralinski L, Menachery V . Return of the Coronavirus: 2019-nCoV. Viruses. 2020; 12(2). PMC: 7077245. DOI: 10.3390/v12020135. View

3.
Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J . The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2022; 613(7942):130-137. DOI: 10.1038/s41586-022-05522-2. View

4.
Moghanibashi-Mansourieh A . Assessing the anxiety level of Iranian general population during COVID-19 outbreak. Asian J Psychiatr. 2020; 51:102076. PMC: 7165107. DOI: 10.1016/j.ajp.2020.102076. View

5.
Sameer A, Khan M, Nissar S, Banday M . Assessment of Mental Health and Various Coping Strategies among general population living Under Imposed COVID-Lockdown Across world: A Cross-Sectional Study. Ethics Med Public Health. 2020; 15:100571. PMC: 7386294. DOI: 10.1016/j.jemep.2020.100571. View